Aerosolized prostacyclin vs placebo
All‐cause mortality · people with ARDS
It is very uncertain whether aerosolized prostacyclin changes mortality compared with placebo (very low certainty).
1 finding from 1 review
- Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS) 2017 · Cochrane Headline outcomes onlyRR 1.5 [0.17, 12.94]1 study · 14 participantsVery low